JUN 23, 2017 02:48 PM PDT

Novel Retinal Scar ID'ed in Ebola Survivors

WRITTEN BY: Xuan Pham

For people who are lucky enough to survive an Ebola infection, the virus doesn't go away without leaving some traces behind. In particular, scientists found that some Ebola survivors have unique scars in the back of their eyes. Such characteristics could lead to potential diagnostic potential for the disease, as well as lend new insight into the biology of the infection.

Image credit: Wikipedia.org

In January 2016, the World Health Organization (WHO) officially declared the end to the largest Ebola outbreak in history. The outbreak ravaged West Africa in 2014 and 2015, killing over 11,000 people and causing a huge international health crisis.

Despite the high mortality rate associated with the disease, some infected people do recover. And in those who survived, scientists wanted to find out whether Ebola left some visible scars.

The scientists studied a group of 82 Ebola survivors from Sierra Leone. Interestingly, when the team examined the eyes of people in this group, they found signs of scarring at the back of their eyes in about 15 percent of the survivors. By contrast, people who lived in the region but were never infected did not have this unique feature.

The retinal lesion varied among those who had it, but “often [resembled] a diamond or wedge shape,” the scientists wrote. Furthermore, they observed that the scar “appears unique” and “is not characteristic of any other retinal disease.” That is, the scars most likely were caused by Ebola exposure.

The team also observed that the scars were most commonly located next to where nerve fibers connect the eye to the brain. Based on this, they postulate the virus’ route of entry into the eyes had to be along the optic nerve.

The appearance of the retinal scars seemed to be superficial, at least in the short-term. People with the scars seemed to perform equally well on vision acuity tests as people without the scars. However, there’s no guarantee that Ebola exposure doesn’t damage vision in the long-term. So far, previous studies indicate that some Ebola survivors experience eye symptoms, like inflammation and temporary vision loss.

Moreover, some Ebola survivors in the current study had cataracts that could be linked to the virus. Fortunately, when the eye fluids of these patients were analyzed, no trace of the virus were found. This suggest the virus doesn’t linger in eye fluids, and that cataract surgery would be safe for these people.

Of note, the Ebola virus causes severe hemorrhagic fevers, which can often be fatal. The natural reservoir for Ebola is still unknown, but humans can get the virus through direct contact with infected blood or body fluids. People infected with Ebola start showing signs and symptoms from 2 to 21 days after exposure. In the beginning stages, symptoms can be non-specific, including fever, muscle pain, headache, and vomiting. Symptoms of hemorrhagic syndrome occur in the advanced stages of infection. There are yet no licensed vaccines or therapies against this virus.

Additional source: Live Science

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 21, 2018
Cardiology
APR 21, 2018
Scientists Recommend Exercise After A Heart Attack
Doctors recommend regular physical activity to reduce the risk of a heart attack, but the same advice applies even after a person has a heart attack. A new...
APR 24, 2018
Cancer
APR 24, 2018
CAR-T Cell Therapy 101
Chimeric antigen receptor T cells (CAR-T cells) have emerged as a useful tool for cancer treatments in a small number of cancers thus far. This area of treatment research is expanding rapidl...
APR 26, 2018
Cardiology
APR 26, 2018
New Gene Linked to Human Aortic Aneurysms
Using a web tool called GeneMatcher, scientists from Baylor College of Medicine studying defective copies of the ari-1 gene were matched up with scientists...
MAY 14, 2018
Clinical & Molecular DX
MAY 14, 2018
Early Differences Between Benign and Malignant Tumors
Physicians are in need of a dependable diagnostic approach for distinguishing between benign and malignant tumors early-on. Once doctors can rule out that ...
JUL 11, 2018
Clinical & Molecular DX
JUL 11, 2018
Certain tests better flag fetuses with brain disorder risk
Fetuses with a specific, rare chromosomal aberration have a 20 percent risk of developmental or other brain disorder, new research shows. The work could le...
AUG 11, 2018
Microbiology
AUG 11, 2018
A Microbrewery can Help us Monitor Radiation Exposure
This wearable technology is very sensitive, and can be used by workers that are at risk of radiation exposure....
Loading Comments...